NCT00360295已完成3 期
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 153
- 试验地点
- 55
- 主要终点
- The primary endpoint is Data Review Committee's Clinical efficacy at Day 8.
研究概览
简要总结
To evaluate the clinical efficacy and safety in patients with mild or moderate community-acquired pneumonia receiving a dose of 2 g of azithromycin in the SR formulation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 80 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who were diagnosed as mild or moderate in severity by the classification of pneumonia "Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: Report of the Committee for the Respiratory System, Japan Society of Chemotherapy (established in 2000)".
排除标准
- •Severe underlying disease; patients in which drug clinical evaluation is difficult because of confounding diseases. ("Severe" assessed by the Severity of underlying diseases and complications of "Clinical evaluation methods for new antimicrobial agents to treat respiratory infections (draft)" by the Japan Society of Chemotherapy (1997)).
结局指标
主要结局
The primary endpoint is Data Review Committee's Clinical efficacy at Day 8.
次要结局
- Data Review Committee's clinical efficacy (at Day 15 and 29) Investigator's clinical efficacy (at Day 8, 15 and 29), and the tendency toward clinical improvement (at Day 4) Bacteriological efficacy (at Day 4, 8, 15 and 29)
- Adverse events and safety Laboratory data
研究者
研究点 (55)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)LeukopeniaNCT00811928Merck Sharp & Dohme LLC252
已完成
不适用
Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic MigraineChronic MigraineNCT04194008Theranica126
进行中（未招募）
1 期
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid TumorsSolid TumorNCT06631079NEC Bio B.V20
已完成
3 期
A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsMyasthenia Gravis ExacerbationsNCT02413580Grifols Therapeutics LLC49
已完成
不适用
A Clinical Evaluation of the LensGen Intraocular LensCataractPresbyopiaNCT05364658LensGen, Inc.61